The situation with the lack of medicines in Europe, according to Spiraka, is due to "interruptions in the production and supply of necessary raw materials from China and India or their decline."
As the MEP added, the current state of affairs was even more complicated due to the fact that a new wave of influenza came to the region "earlier than expected."
“Increasing prices for previously cheap pharmaceuticals is being considered as a possible means of combating global shortages, provided that the main burden of such a measure does not fall on patients,” Spiraki said.
However, against the background of the “catastrophic impact” of the growing shortage of drugs on patients, Spiraki asked the European Commission what “urgent measures” they intend to take to solve this problem and increase the production of drugs in Europe.
“What funding is currently available to EU member states to encourage increased production and absorb possible price increases?”
the parliamentarian also asked.
Earlier, the European media reported that in the European Union there is
lack of medicines.
Among others, antibiotics, drugs against influenza and other respiratory infections became scarce.
According to European Commissioner for Health Stella Kyriakides, European governments are taking measures to overcome the deficit.